Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M29,741Revenue $M91,084Net Margin (%)1.2Z-Score4.9
Enterprise Value $M30,836EPS $3.4Operating Margin %2.0F-Score7
P/E(ttm))27.9Cash Flow Per Share $4.2Pre-tax Margin (%)1.9Higher ROA y-yY
Price/Book4.910-y EBITDA Growth Rate %0.4Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.35-y EBITDA Growth Rate %7.1Current Ratio1.2Lower Leverage y-yY
Price/Cash Flow9.8y-y EBITDA Growth Rate %61.4ROA % (ttm)4.3Higher Current Ratio y-yN
Dividend Yield %1.5Insider Buy (3m)0ROE % (ttm)17.3Less Shares Outstanding y-yY
Payout Ratio %41.0Shares Outstanding M330ROI % (ttm)3.5Gross Margin Increase y-yY

Gurus Latest Trades with CAH

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CAHJoel Greenblatt 2014-12-31 Reduce-0.08%$72.13 - $83.04
($79.1)
$ 90.0912%Reduce -31.17%243,387
CAHJoel Greenblatt 2014-09-30 Reduce-0.28%$69.59 - $77.66
($72.84)
$ 90.0919%Reduce -48.00%353,619
CAHRay Dalio 2014-09-30 Sold Out -0.01%$69.59 - $77.66
($72.84)
$ 90.0919%Sold Out0
CAHJoel Greenblatt 2014-06-30 Add0.26%$63.8 - $71.31
($68.07)
$ 90.0924%Add 79.29%680,062
CAHRay Dalio 2014-06-30 Reduce-0.02%$63.8 - $71.31
($68.07)
$ 90.0924%Reduce -77.82%10,834
CAHJames Barrow 2014-03-31 Reduce-0.15%$65.26 - $73.54
($69.45)
$ 90.0923%Reduce -18.44%6,958,722
CAHJoel Greenblatt 2014-03-31 Add0.13%$65.26 - $73.54
($69.45)
$ 90.0923%Add 47.40%379,308
CAHRay Dalio 2014-03-31 Add0.01%$65.26 - $73.54
($69.45)
$ 90.0923%Add 90.45%48,844
CAHVanguard Health Care Fund 2013-12-31 Reduce-0.59%$52.95 - $67.48
($61.19)
$ 90.0932%Reduce -39.27%5,043,241
CAHJames Barrow 2013-12-31 Reduce-0.25%$52.95 - $67.48
($61.19)
$ 90.0932%Reduce -25.92%8,532,117
CAHJoel Greenblatt 2013-12-31 Add0.18%$52.95 - $67.48
($61.19)
$ 90.0932%Add 78.81%257,325
CAHJohn Keeley 2013-12-31 Add0.05%$52.95 - $67.48
($61.19)
$ 90.0932%Add 33.23%164,270
CAHRay Dalio 2013-12-31 Reduce-0.02%$52.95 - $67.48
($61.19)
$ 90.0932%Reduce -65.96%25,646
CAHDavid Dreman 2013-12-31 Sold Out -0.01%$52.95 - $67.48
($61.19)
$ 90.0932%Sold Out0
CAHJoel Greenblatt 2013-09-30 Add0.21%$47.02 - $53.57
($50.83)
$ 90.0944%Add 772.85%143,906
CAHDavid Dreman 2013-09-30 Reduce-0.13%$47.02 - $53.57
($50.83)
$ 90.0944%Reduce -97.55%2,019
CAHRay Dalio 2013-09-30 Add0.01%$47.02 - $53.57
($50.83)
$ 90.0944%Add 62.57%75,346
CAHJohn Hussman 2013-09-30 Sold Out -0.01%$47.02 - $53.57
($50.83)
$ 90.0944%Sold Out0
CAHJames Barrow 2013-06-30 Add0.44%$41.85 - $48.76
($45.67)
$ 90.0949%Add 109.21%10,534,000
CAHJoel Greenblatt 2013-06-30 Reduce-0.06%$41.85 - $48.76
($45.67)
$ 90.0949%Reduce -64.59%16,487
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CAH is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CAH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Arnold Colleen F.Director 2015-03-04Sell9,801$87.651.7view
NOTEBAERT RICHARD CDirector 2015-03-03Sell9,801$88.21.07view
DARDEN CALVINDirector 2015-03-03Sell9,801$87.851.47view
WATKINS CAROLE SChief HR Officer 2015-02-20Sell33,847$872.46view
Barrett George SChairman and CEO 2015-02-10Sell300,000$84.875.03view
WATKINS CAROLE SChief HR Officer 2015-02-10Sell50,770$854.87view
Giacomin Jon LCEO, Pharmaceutical Segment 2014-11-11Sell0$04.87view
Blake Mark REVP - Strategy & Corp. Dev. 2014-11-07Sell24,668$79.512.13view
MORRISON PATRICIAChief Information Officer 2014-11-05Sell0$012.13view
WATKINS CAROLE SChief HR Officer 2014-09-05Sell40,794$7518.85view

Press Releases about CAH :

    Quarterly/Annual Reports about CAH:

    News about CAH:

    Articles On GuruFocus.com
    My Stocks Mar 06 2015 
    Johnson & Johnson Has A Potential Buyer For Its Medical Devices Unit Feb 24 2015 
    Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
    AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
    Dividend Aristocrats In Focus Part 26 of 54: Walgreens Oct 23 2014 
    Dividend Aristocrats In Focus Part 20 of 54: Cardinal Health Oct 16 2014 
    AmerisourceBergen Is a Center Piece in the Pharma Industry Sep 30 2014 
    Top Insider Sells Highlight: Cardinal Health Inc. Jul 17 2014 
    Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
    8 Dividend Stocks with a 15% Yield in 15 Years May 14 2014 


    More From Other Websites
    The Time Is Now To Fully Measure ROI Of Medication Therapy Management Mar 25 2015
    The Time Is Now To Fully Measure ROI Of Medication Therapy Management Mar 25 2015
    Zacks.com featured expert Kevin Matras highlights: Flextronics Int'l, CDW, Tilly's, Citi Trends and... Mar 25 2015
    Henry Schein (HSIC) Enters S&P 500, Shares Up - Analyst Blog Mar 23 2015
    Patterson Rewards Shareholders with 10% Dividend Hike - Analyst Blog Mar 20 2015
    Cerner Inks Agreement to Digitize Healthcare in Washington - Analyst Blog Mar 19 2015
    DENTSPLY: Product Portfolio Strong, Currency Woes Remain - Analyst Blog Mar 19 2015
    CONMED: Strong Sell on Dismal Q4 Results, Estimate Revision - Analyst Blog Mar 18 2015
    Becton, Dickinson & CareFusion Unite; Moody's Not Happy - Analyst Blog Mar 18 2015
    PharMerica Corporation Announces Wholesale Drug Distribution Agreement with Cardinal Health Mar 15 2015
    Hard Data Can Help Health Systems Improve Economic Performance Mar 14 2015
    Cardinal Health Highlights Nurse Education, Community Connections at AORN Surgical Conference and... Mar 11 2015
    The Morning Ledger: Why CFOs Should Look Past Numbers to Evaluate a Deal Mar 06 2015
    Cardinal Health CFO: Deal Making Isn't Just About Numbers Mar 06 2015
    Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE Mar 05 2015
    Credit Suisse: 8 Biotech and Health Care Stocks Add to Your Portfolio Right Now Mar 05 2015
    Cardinal Health Set to Buy Cordis, Shares Hit 52-Week High - Analyst Blog Mar 03 2015
    Cardinal Health Named One of the "Top 50 Companies for Executive Women" by NAFE Mar 03 2015
    Nasdaq Composite Ends Above 5000 for First Time Since Dot-Com Era Mar 03 2015
    Cramer: Market headed for froth-time to sell? Mar 02 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK